Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

(2010) M. Hingorani et al.   CURRENT CANCER DRUG TARGETS

Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene

(2009) P. Brader et al.   CLINICAL CANCER RESEARCH

Oncolytic vaccinia therapy of squamous cell carcinoma

(2009) Zhenkun Yu et al.   Molecular Cancer

Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68

(2009) Y. A. Yu et al.   MOLECULAR CANCER THERAPEUTICS

Unknown

(2009) Nanhai Chen et al.   MOLECULAR MEDICINE

Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent

(2008) I Gentschev et al.   CANCER GENE THERAPY

Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma

(2008) Kaitlyn J. Kelly et al.   HUMAN GENE THERAPY

Real-time intraoperative detection of melanoma lymph node metastases using recombinant vaccinia virus GLV-1h68 in an immunocompetent animal model

(2008) Kaitlyn J. Kelly et al.   INTERNATIONAL JOURNAL OF CANCER

Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancerin Vivo

(2008) Shu-Fu Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human Prostate

(2008) Kenneth N Barton et al.   MOLECULAR THERAPY